MOSCOW-A renowned plant sciences institute in St. Petersburg is facing eviction because of the Russian government's desire to beef up its presence in the former Imperial capital. The All-Russian Vavilov Institute of Plant Industry, home to the world's oldest and second-largest plant gene bank, has already beaten off one attempt by city authorities. But this time, its opponent is none other than Russian President Vladimir Putin, a St. Petersburg native. This is not the first time that Vavilov researchers have found themselves staring into the abyss. A decade ago, after the Soviet Union unraveled, the institute received $5.5 million from Western institutions for repairs and renovations to facilities housing its vaunted collection of 320,000 plant germ-plasm accessions.
The latest threat originated last year, when officials in the office of St. Petersburg vice governor Valeriy Nazarov, the federally appointed chair of the City Property Administration Committee, hatched a plan to acquire one of the Vavilov's buildings. The institute hit back with a civil suit, arguing that the land grab was illegal because the building's owner is the Russian Academy of Agricultural Sciences. The Vavilov has occupied the building in question since 1930, some 36 years after it was erected for the Russian Ministry of Agriculture. Last month, the court found for the institute; last week, Nazarov's off ice announced that it would appeal.
The appeal is backed by a federal decree, issued 17 December, that transfers control of both of the institute's buildings from the Agricultural Academy to the Putin administration. "The president wants to move bureaucrats from Moscow into our building," says the institute's director, Viktor Dragavtsev. "If they take it, we will have nowhere to go." He estimates that relocation into new facilities would cost $70 million, including roughly $30 million for a new germ-plasm storage facility. Nazarov declined to speak with Science.
Western experts hope that Russian officials will recognize the value of the Vavilov's germ plasm before inflicting irreparable damage. "It's a very important collection.
Anything that threatens its ability to keep operating matters deeply, not just to Russia but to the entire world," says Ruth Raymond, coordinator of the Global Conservation Trust at the International Plant Genetic Resources Institute in Rome, which is campaigning to raise $250 million to preserve international crop-diversity collections such as the Vavilov's. "The government must make provision for the collection," she says; "otherwise it will be a tragedy."
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Bill Gates Plans a Hit List, With NIH's Help
The richest man on Earth has a new plan to help the poorest-and maybe inspire others to follow him. Last Sunday, software tycoon Bill Gates announced that his philanthropic organization will spend $200 million on research into the diseases that plague developing countries, in a process that he hopes will entice other research organizations to take up the cause. The U.S. National Institutes of Health (NIH) and its director, Elias Zerhouni, are partners in the plan.
The program's key element is to create a list of "Grand Challenges," about 10 concrete research projects that, if successful, could make a huge dent in human disease and suffering worldwide. The objectives will be drawn up by top scientists over the next half-year and published. The Bill and Melinda Gates Foundation will then give research groups up to $20 million each to address them over the next 3 or 4 years. The foundation hopes the global todo list will stimulate complementary research and lure young scientists.
Gates, who presented the plan at the World Economic Forum in Davos, Switzerland, says he was inspired by David Hilbert, a renowned German mathematician who formulated a set of unsolved math problems in 1900 that stimulated the f ield for decades. Noting at a press conference that some of the world's most deadly diseases are chronically underfunded, Gates said that he hoped a similar list of health problems would help attract resources for a focused assault. Among the potential challenges identified by the foundation are a drug that prevents latent tuberculosis from resurging and a malaria-resistant mosquito. "These will be risky things," Gates said. "No guarantee of success."
The new program will be administered by the Foundation for the National Institutes of Health, a nonprofit corporation associated with NIH that allows the agency to accept money from nonfederal sources. NIH will help in a variety of ways, Zerhouni saysfor instance, by offering advice or collaborating on grant proposals.
Zerhouni, who will be a member of the panel that defines the grand challenges and picks the awardees, calls the list "an interesting model to watch. … Let's see if it works." Other panel members are Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, director Julie Gerberding of the Centers for Disease Control and Prevention, and top scientists from developing countries. The chair is Nobel laureate Harold Varmus, a former NIH director who now heads the Memorial SloanKettering Cancer Center in New York City.
Others global health experts are enthusiastic. Gates has "a fascinating idea, money, and the right people," says George Rutherford, interim director of the Institute for Global Health in San Francisco. "It's the perfect storm." 
